Samjin Pharmaceuticals Co., Ltd.
KRX:005500.KS
18210 (KRW) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) KRW.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 292,128.534 | 274,031.808 | 250,070.356 | 235,164.889 | 241,926.177 | 260,016.571 | 245,271.928 | 239,312.894 | 216,511.472 | 201,305.29 | 192,006.713 | 185,702.08 | 201,756.104 | 200,410.515 | 165,388.711 | 147,996.742 | 137,112.663 |
| Cost of Revenue
| 146,236.922 | 156,297.385 | 132,238.372 | 124,648.844 | 121,212.525 | 117,237.366 | 109,290.239 | 109,965.954 | 96,672.602 | 89,313.975 | 75,040.55 | 77,519.871 | 80,316.013 | 79,878.962 | 69,268.945 | 56,259.138 | 50,829.288 |
| Gross Profit
| 145,891.612 | 117,734.423 | 117,831.983 | 110,516.045 | 120,713.652 | 142,779.206 | 135,981.689 | 129,346.94 | 119,838.869 | 111,991.315 | 116,966.163 | 108,182.209 | 121,440.091 | 120,531.553 | 96,119.766 | 91,737.604 | 86,283.375 |
| Gross Profit Ratio
| 0.499 | 0.43 | 0.471 | 0.47 | 0.499 | 0.549 | 0.554 | 0.54 | 0.553 | 0.556 | 0.609 | 0.583 | 0.602 | 0.601 | 0.581 | 0.62 | 0.629 |
| Reseach & Development Expenses
| 35,430.449 | 3,657.764 | 2,581.928 | 1,507.195 | 2,601.799 | 3,743.958 | 3,645.556 | 2,798.69 | 2,769.98 | 3,293.534 | 7,619.453 | 11,029.892 | 10,425.054 | 8,776.314 | 6,121.791 | 4,020.716 | 3,065.228 |
| General & Administrative Expenses
| 15,149.727 | 17,144.905 | 15,053.771 | 13,955.109 | 13,444.239 | 19,703.45 | 21,630.637 | 22,218.789 | 23,472.234 | 22,623.715 | 23,454.136 | 23,426.592 | 22,116.949 | 19,700.489 | 19,731.916 | 19,173.311 | 17,506.87 |
| Selling & Marketing Expenses
| 26,313.194 | 25,565.405 | 19,708.94 | 19,067.031 | 15,155.106 | 20,079.108 | 24,077.296 | 24,209.585 | 22,503.42 | 21,094.056 | 20,991.786 | 24,136.223 | 32,570.86 | 36,712.552 | 31,823.44 | 30,423.309 | 25,882.752 |
| SG&A
| 90,323.602 | 42,710.31 | 34,762.711 | 33,022.14 | 28,599.345 | 39,782.558 | 45,707.933 | 46,428.374 | 45,975.654 | 43,717.771 | 44,445.922 | 47,562.815 | 54,687.809 | 56,413.041 | 51,555.356 | 49,596.62 | 43,389.622 |
| Other Expenses
| -639.205 | 48,182.027 | 46,575.918 | 43,744.702 | 44,615.904 | 90.759 | -392.101 | -292.587 | -90.114 | -127.687 | 161.468 | -777.849 | 32,326.422 | -79.631 | -587.075 | -1,243.335 | -2,967.356 |
| Operating Expenses
| 126,393.256 | 94,550.101 | 83,920.557 | 78,274.037 | 75,817.048 | 83,237.5 | 89,035.149 | 87,288.843 | 83,873.268 | 80,414.471 | 86,872.262 | 90,864.567 | 97,439.285 | 98,451.261 | 84,119.409 | 79,161.153 | 69,571.936 |
| Operating Income
| 19,498.355 | 23,184.322 | 33,911.426 | 32,242.008 | 22,205.297 | 59,541.705 | 46,946.54 | 42,058.097 | 35,965.601 | 31,576.844 | 30,093.9 | 17,317.642 | 23,906.673 | 22,080.294 | 12,000.36 | 12,576.451 | 16,711.439 |
| Operating Income Ratio
| 0.067 | 0.085 | 0.136 | 0.137 | 0.092 | 0.229 | 0.191 | 0.176 | 0.166 | 0.157 | 0.157 | 0.093 | 0.118 | 0.11 | 0.073 | 0.085 | 0.122 |
| Total Other Income Expenses Net
| -3,901.71 | 2,041.929 | 999.813 | 587.62 | -333.668 | 508.466 | -474.115 | -3,113.897 | -1,370.882 | -1,420.694 | -1,470.592 | -2,256.783 | -2,143.966 | -6,427.53 | -2,076.337 | -2,785.644 | -4,145.14 |
| Income Before Tax
| 15,596.646 | 25,226.251 | 34,911.239 | 32,829.628 | 21,871.629 | 60,050.172 | 46,472.425 | 38,944.2 | 34,594.719 | 30,156.15 | 28,623.308 | 15,060.859 | 21,856.839 | 15,652.762 | 9,924.02 | 9,790.807 | 12,566.299 |
| Income Before Tax Ratio
| 0.053 | 0.092 | 0.14 | 0.14 | 0.09 | 0.231 | 0.189 | 0.163 | 0.16 | 0.15 | 0.149 | 0.081 | 0.108 | 0.078 | 0.06 | 0.066 | 0.092 |
| Income Tax Expense
| -3,348.649 | 3,325.332 | 6,507.083 | 4,950.32 | 9,990.872 | 34,523.986 | 10,676.6 | 8,769.869 | 7,551.548 | 9,439.432 | 20,745.115 | 4,422.416 | 14,794.376 | 5,175.566 | 2,879.046 | 3,058.992 | 6,131.696 |
| Net Income
| 18,905.784 | 21,893.836 | 28,404.156 | 27,879.308 | 11,880.757 | 25,526.185 | 35,795.825 | 30,174.332 | 27,043.171 | 20,716.718 | 7,878.194 | 10,638.443 | 7,062.464 | 10,477.195 | 7,044.974 | 6,731.815 | 6,434.603 |
| Net Income Ratio
| 0.065 | 0.08 | 0.114 | 0.119 | 0.049 | 0.098 | 0.146 | 0.126 | 0.125 | 0.103 | 0.041 | 0.057 | 0.035 | 0.052 | 0.043 | 0.045 | 0.047 |
| EPS
| 1,459.66 | 1,727.82 | 2,308.75 | 2,266.09 | 917.07 | 2,075.29 | 2,891 | 2,423 | 2,172 | 1,664 | 627 | 817 | 542 | 817 | 548.87 | 525.07 | 496.85 |
| EPS Diluted
| 1,459.66 | 1,727.82 | 2,308.75 | 2,266.09 | 917.07 | 2,075.29 | 2,891 | 2,423 | 2,172 | 1,664 | 627 | 817 | 542 | 817 | 548.87 | 525.07 | 496.85 |
| EBITDA
| 36,111.111 | 33,821.841 | 41,620.371 | 39,335.23 | 28,677.096 | 66,508.02 | 53,413.631 | 48,922.952 | 42,671.517 | 37,898.26 | 35,968.126 | 20,939.184 | 27,575.485 | 26,271.722 | 15,267.263 | 14,832.022 | 16,771.059 |
| EBITDA Ratio
| 0.124 | 0.123 | 0.166 | 0.167 | 0.119 | 0.256 | 0.218 | 0.204 | 0.197 | 0.188 | 0.187 | 0.113 | 0.137 | 0.131 | 0.092 | 0.1 | 0.122 |